PubMed

Randomized dose ranging study of the reduction of fasting and postprandial glucose in type 2 diabetes by nateglinide (A-4166).

Gribble FM, Manley SE, Levy JC.

Diabetes Care. 2001 Jul;24(7):1221-5.PMID: 11423506 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.

Tuomi T, Honkanen EH, Isomaa B, Sarelin L, Groop LC.

Diabetes Care. 2006 Feb;29(2):189-94.PMID: 16443858 [PubMed - indexed for MEDLINE]Related articlesFree article

Importance of early insulin secretion: comparison of nateglinide and glyburide in previously diet-treated patients with type 2 diabetes.

Hollander PA, Schwartz SL, Gatlin MR, Haas SJ, Zheng H, Foley JE, Dunning BE.

Diabetes Care. 2001 Jun;24(6):983-8.PMID: 11375357 [PubMed - indexed for MEDLINE]Related articlesFree article

Control of postprandial hyperglycemia: optimal use of short-acting insulin secretagogues.

Carroll MF, Izard A, Riboni K, Burge MR, Schade DS.

Diabetes Care. 2002 Dec;25(12):2147-52.PMID: 12453952 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and safety of nateglinide in type 2 diabetic patients with modest fasting hyperglycemia.

Saloranta C, Hershon K, Ball M, Dickinson S, Holmes D.

J Clin Endocrinol Metab. 2002 Sep;87(9):4171-6.PMID: 12213867 [PubMed - indexed for MEDLINE]Related articlesFree article

Nateglinide alone and in combination with metformin improves glycemic control by reducing mealtime glucose levels in type 2 diabetes.

Horton ES, Clinkingbeard C, Gatlin M, Foley J, Mallows S, Shen S.

Diabetes Care. 2000 Nov;23(11):1660-5.PMID: 11092289 [PubMed - indexed for MEDLINE]Related articlesFree article

A placebo-controlled crossover study comparing the effects of nateglinide and glibenclamide on postprandial hyperglycaemia and hyperinsulinaemia in patients with type 2 diabetes.

Barnett AH, Anderson DM, Shelley S, Morgan R, Owens DR.

Diabetes Obes Metab. 2004 Mar;6(2):104-13.PMID: 14746575 [PubMed - indexed for MEDLINE]Related articles

Rapid and short-acting mealtime insulin secretion with nateglinide controls both prandial and mean glycemia.

Hanefeld M, Bouter KP, Dickinson S, Guitard C.

Diabetes Care. 2000 Feb;23(2):202-7.PMID: 10868832 [PubMed - indexed for MEDLINE]Related articlesFree article

Addition of nateglinide to rosiglitazone monotherapy suppresses mealtime hyperglycemia and improves overall glycemic control.

Fonseca V, Grunberger G, Gupta S, Shen S, Foley JE.

Diabetes Care. 2003 Jun;26(6):1685-90.PMID: 12766094 [PubMed - indexed for MEDLINE]Related articlesFree article

Improved control of mealtime glucose excursions with coadministration of nateglinide and metformin.

Hirschberg Y, Karara AH, Pietri AO, McLeod JF.

Diabetes Care. 2000 Mar;23(3):349-53.PMID: 10868864 [PubMed - indexed for MEDLINE]Related articlesFree article

Synergistic effects of nateglinide and meal administration on insulin secretion in patients with type 2 diabetes mellitus.

Keilson L, Mather S, Walter YH, Subramanian S, McLeod JF.

J Clin Endocrinol Metab. 2000 Mar;85(3):1081-6.PMID: 10720043 [PubMed - indexed for MEDLINE]Related articlesFree article

Nateglinide improves early insulin secretion and controls postprandial glucose excursions in a prediabetic population.

Saloranta C, Guitard C, Pecher E, De Pablos-Velasco P, Lahti K, Brunel P, Groop L.

Diabetes Care. 2002 Dec;25(12):2141-6.PMID: 12453951 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy and tolerability of initial combination therapy with nateglinide and metformin in treatment-naïve patients with type 2 diabetes.

Horton ES, Foley JE, Shen SG, Baron MA.

Curr Med Res Opin. 2004 Jun;20(6):883-9.PMID: 15200747 [PubMed - indexed for MEDLINE]Related articles

Hypoglycemic potential of nateglinide versus glyburide in patients with type 2 diabetes mellitus.

Fonseca VA, Kelley DE, Cefalu W, Baron MA, Purkayastha D, Nestler JE, Hsia S, Gerich JE.

Metabolism. 2004 Oct;53(10):1331-5. Erratum in: Metabolism. 2005 May;54(5):698. PMID: 15375790 [PubMed - indexed for MEDLINE]Related articles

Comparison of nateglinide and gliclazide in combination with metformin, for treatment of patients with Type 2 diabetes mellitus inadequately controlled on maximum doses of metformin alone.

Ristic S, Collober-Maugeais C, Pecher E, Cressier F.

Diabet Med. 2006 Jul;23(7):757-62.PMID: 16842480 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of nateglinide and glibenclamide on postprandial lipid and glucose metabolism in type 2 diabetes.

Vakkilainen J, Mero N, Schweizer A, Foley JE, Taskinen MR.

Diabetes Metab Res Rev. 2002 Nov-Dec;18(6):484-90.PMID: 12469362 [PubMed - indexed for MEDLINE]Related articles

Evaluation of a new insulinotropic agent by using an innovative technology: efficacy and safety of nateglinide determined by continuous glucose monitoring.

Abrahamian H, Francesconi M, Loiskandl A, Dzien A, Prager R, Weitgasser R.

Diabetes Technol Ther. 2004 Feb;6(1):31-7.PMID: 15000767 [PubMed - indexed for MEDLINE]Related articles

PRESERVE-beta: two-year efficacy and safety of initial combination therapy with nateglinide or glyburide plus metformin.

Gerich J, Raskin P, Jean-Louis L, Purkayastha D, Baron MA.

Diabetes Care. 2005 Sep;28(9):2093-9.PMID: 16123472 [PubMed - indexed for MEDLINE]Related articlesFree article

Mealtime glucose regulation by nateglinide in type-2 diabetes mellitus.

Walter YH, Spratt DI, Garreffa S, McLeod JF.

Eur J Clin Pharmacol. 2000 May;56(2):129-33.PMID: 10877006 [PubMed - indexed for MEDLINE]Related articles

Nateglinide and glibenclamide metabolic effects in naïve type 2 diabetic patients treated with metformin.

Derosa G, D'Angelo A, Fogari E, Salvadeo S, Gravina A, Ferrari I, Cicero AF.

J Clin Pharm Ther. 2009 Feb;34(1):13-23.PMID: 19125899 [PubMed - indexed for MEDLINE]Related articles